Gregory Helmer, MD, FACC

Philosophy of Care:

Active in research, Dr. Helmer's special interests include interventional cardiology, as well as angiogenesis for collateral blood vessel growth.

Medical Title:

Academic Appointments:



Clinical Interests:

Languages Spoken:


Board Certifications:

Helmer, G.A., McKirnan, D., Shabetai, R., Boss, G.R., Ross, J.R., Hammond, H.K. “Regional Deficits of Myocardial Blood Flow and Function in Ventricular Pacing-induced Heart Failure.” Circulation, Volume 94, No 9, November 1, 1996.

Roth, D.A., Urasawa, K., Helmer, G.A., Hammond, H.D. “Down-regulation of Cardiac GTP-binding Proteins In Right Atrium and Left Ventricle in Pacing-induced Congestive Heart Failure.” J.Clin Invest, 91:939-949, 1993.

Grines, C.L., Watkins, M.W., Helmer, G.A., Penny, W. Brinker, Marmur, J., West, A., Rade, J., Marrott, P. Hammond, H.K., Engler, R.L. “Angiogenic Gene Therapy (AGENT) Trial in Patients with Stable Angina Pectoris.” Circulation. March 19, 2002; 105:1291 – 1297.

Rude, D.J., Koralesky, A., Helmer, G.A., Henry, T. “Successful Percutaneous Coronary Intervention in Patients with Antiphospholipid Antibody Syndrome.” Submitted American Heart Journal August 2003.

Helmer, G.A., Dalton, N., Hammond, H.K. “Left Ventricular Size and End-systolic Pressure-Dimension Relationship During Chronic Rapid Pacing-induced Congestive Heart Failure.” Clin Res 41:232A, 1993.

Hammond, H.D., McKay, R., Ford, C.E., McKirnan, M.D., Roth, D.A., Helmer, G.A. “Chronic Episodic Ischemia Is Associated With Decreased B-adrenergic Receptor Number and Pertussis Toxin Substrate.” Clin Res 39:154A, 1991.

Helmer, G.A., McKirnan, DeMaria, A., Hammond, H.K. “Abnormalities of Regional Myocardial Contraction and Perfusion in Pacing-induced Cardiomyopathy: Detection by Ultrasonic Integrated Backskatter.” Circulation, November, 1993.

Grines, C.L., Watkins, M.W., Helmer, G.A., Penny, W., Brinker, J., Marmur, J., West, A., Rade, J., Marrott, P., Hammond, H.K., Engler, R.L. “Angiogenic Gene Therapy (AGENT) Trial in Patients with Stable Angina Pectoris.” Presented ACC meeting March, 19, 2001.

Watkins, M.W. Grines, C.L. for the AGENT – 2 Study Group. “Intracoronary Angiogenic Gene Therapy is Well Tolerated in Patients with Coronary Artery Disease” –presented at the European Society of Cardiology meeting September, 2003 and AHA meeting November, 2003.

Gerhard JJ, Gundu HR, Ganesh Raveendram, Laxson DD, Helmer GA, Haworth B: “Measurement of Platelet Activation in Response to Shear Stress in Patients with Arterial Vascular Risk Factors and Disease” Poster presentation at PLATELETS 208 INTERNATIONAL SYMPOSIUM, Oct. 15-18, 2008.

Discrimination is Against the Law. We comply with applicable Federal civil rights laws and Minnesota laws. We do not discriminate against, exclude or treat people differently because of race, color, national origin, age, disability, sex, sexual orientation or gender identity. Please see our Patients’ Bill of Rights.
 Visit Other Fairview Sites 
(c) 2017 Fairview Health Services. All rights reserved.